Concurrently, CircMETTL14 (11) S exacerbates inflammation in ECs and promote the progression of atherosclerosis through the Methyltransferase-like 14 (METTL14)/C-X-C chemokine receptor type 4 (CXCR4) axis (61). Here, METTL14 is linked to atherosclerosis.